Prevalence of and factors associated with receipt of provider recommendation for influenza vaccination and uptake of influenza vaccination during pregnancy: cross-sectional study.
Adult
Cross-Sectional Studies
Female
Germany
Health Knowledge, Attitudes, Practice
Humans
Influenza Vaccines
Influenza, Human
/ prevention & control
Patient Acceptance of Health Care
Pregnancy
Pregnancy Complications, Infectious
/ prevention & control
Prenatal Care
Referral and Consultation
Seasons
Vaccination
/ statistics & numerical data
Influenza
Pregnancy
Recommendation
Uptake
Vaccine
Journal
BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799
Informations de publication
Date de publication:
27 Oct 2021
27 Oct 2021
Historique:
received:
07
02
2021
accepted:
28
09
2021
entrez:
28
10
2021
pubmed:
29
10
2021
medline:
1
1
2022
Statut:
epublish
Résumé
Seasonal influenza vaccination has been recommended for pregnant women in Germany since 2010. The aim of this study was to examine prevalence and determinants of receipt of provider recommendation for influenza vaccination as well as influenza vaccination uptake during pregnancy. We analysed data from the "KUNO Kids Health Study", a prospective birth cohort. During the study period (5th July 2015 to 27th June 2018) data were collected from participating mothers by interview and questionnaire. According to Andersen's behavioural model of health services use potential influencing factors describing the circumstances and characteristics of the mothers and their pregnancies which are potentially affecting whether women receive a recommendation for a vaccination or whether they utilize influenza vaccination were classified into three domains: 'predisposing characteristics', 'enabling resources' and 'need'. Using multivariable logistic regression models odds ratios (OR) and corresponding 95% confidence intervals (95% CI) were calculated. As a combined result across three flu seasons, 368 of 1814 (20.3%) women received an influenza vaccination recommendation during pregnancy. Having had a high-risk pregnancy increased the odds of receiving a vaccination recommendation (OR = 1.3; 95% CI = 1.0-1.6; p = 0.045). In contrast, pregnancy onset in summer (OR = 0.7; 95% CI = 0.5-1.0; p = 0.027), autumn (OR = 0.4; 95% CI = 0.3-0.5; p < =0.001) or winter (OR = 0.5; 95% CI = 0.3-0.6; p < =0.001) (compared to spring) as well as mother's birthplace outside Germany (OR = 0.6; 95% CI = 0.4-0.9; p = 0.023) reduced the chance of getting a vaccination recommendation. Two hundred forty-two of one thousand eight hundred sixty-five (13%) women were vaccinated against influenza during pregnancy. Having received a vaccination recommendation was strongly associated with vaccination uptake (OR = 37.8; 95% CI = 25.5-55.9; p < =0.001). Higher health literacy status was also associated with a higher chance of vaccination uptake (OR = 1.7; 95% CI = 1.2-2.6; p = 0.008), whereas pregnancy onset in autumn (compared to spring) reduced the chance (OR = 0.5; 95% CI = 0.3-0.8; p = 0.008). At 13% the uptake rate of influenza vaccination is low. Having received a recommendation to vaccinate was strongly associated with uptake but only one fifth of all mothers report such a recommendation. Raising awareness in physicians regarding vaccinating during pregnancy seems to be of essential importance to increase vaccine uptake and to prevent influenza-related complications in pregnant women.
Sections du résumé
BACKGROUND
BACKGROUND
Seasonal influenza vaccination has been recommended for pregnant women in Germany since 2010. The aim of this study was to examine prevalence and determinants of receipt of provider recommendation for influenza vaccination as well as influenza vaccination uptake during pregnancy.
METHODS
METHODS
We analysed data from the "KUNO Kids Health Study", a prospective birth cohort. During the study period (5th July 2015 to 27th June 2018) data were collected from participating mothers by interview and questionnaire. According to Andersen's behavioural model of health services use potential influencing factors describing the circumstances and characteristics of the mothers and their pregnancies which are potentially affecting whether women receive a recommendation for a vaccination or whether they utilize influenza vaccination were classified into three domains: 'predisposing characteristics', 'enabling resources' and 'need'. Using multivariable logistic regression models odds ratios (OR) and corresponding 95% confidence intervals (95% CI) were calculated.
RESULTS
RESULTS
As a combined result across three flu seasons, 368 of 1814 (20.3%) women received an influenza vaccination recommendation during pregnancy. Having had a high-risk pregnancy increased the odds of receiving a vaccination recommendation (OR = 1.3; 95% CI = 1.0-1.6; p = 0.045). In contrast, pregnancy onset in summer (OR = 0.7; 95% CI = 0.5-1.0; p = 0.027), autumn (OR = 0.4; 95% CI = 0.3-0.5; p < =0.001) or winter (OR = 0.5; 95% CI = 0.3-0.6; p < =0.001) (compared to spring) as well as mother's birthplace outside Germany (OR = 0.6; 95% CI = 0.4-0.9; p = 0.023) reduced the chance of getting a vaccination recommendation. Two hundred forty-two of one thousand eight hundred sixty-five (13%) women were vaccinated against influenza during pregnancy. Having received a vaccination recommendation was strongly associated with vaccination uptake (OR = 37.8; 95% CI = 25.5-55.9; p < =0.001). Higher health literacy status was also associated with a higher chance of vaccination uptake (OR = 1.7; 95% CI = 1.2-2.6; p = 0.008), whereas pregnancy onset in autumn (compared to spring) reduced the chance (OR = 0.5; 95% CI = 0.3-0.8; p = 0.008).
CONCLUSIONS
CONCLUSIONS
At 13% the uptake rate of influenza vaccination is low. Having received a recommendation to vaccinate was strongly associated with uptake but only one fifth of all mothers report such a recommendation. Raising awareness in physicians regarding vaccinating during pregnancy seems to be of essential importance to increase vaccine uptake and to prevent influenza-related complications in pregnant women.
Identifiants
pubmed: 34706672
doi: 10.1186/s12884-021-04182-w
pii: 10.1186/s12884-021-04182-w
pmc: PMC8549148
doi:
Substances chimiques
Influenza Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
723Informations de copyright
© 2021. The Author(s).
Références
BMC Public Health. 2013 Oct 10;13:948
pubmed: 24112855
Geburtshilfe Frauenheilkd. 2017 Apr;77(4):340-351
pubmed: 28552997
Hum Vaccin Immunother. 2014;10(10):2922-9
pubmed: 25483464
Clin Infect Dis. 2009 Dec 15;49(12):1784-92
pubmed: 19911967
BMJ. 2011 Jun 14;342:d3214
pubmed: 21672992
Med J Aust. 2013 Apr 15;198(7):373-5
pubmed: 23581957
CMAJ. 2007 Feb 13;176(4):463-8
pubmed: 17296958
Psychosoc Med. 2012;9:Doc11
pubmed: 23133505
Am J Public Health. 2012 Jun;102(6):e33-40
pubmed: 22515877
Am J Obstet Gynecol. 2009 Dec;201(6):547-52
pubmed: 19850275
Vaccine. 2013 Jun 12;31(27):2874-8
pubmed: 23623863
Vaccine. 2013 Oct 25;31(45):5281-8
pubmed: 24016814
Lancet. 2009 Aug 8;374(9688):451-8
pubmed: 19643469
Mol Cell Pediatr. 2019 Jan 9;6(1):1
pubmed: 30627823
PLoS Med. 2011 May;8(5):e1000441
pubmed: 21655318
Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S58-63
pubmed: 21457913
Am J Obstet Gynecol. 2005 Apr;192(4):1098-106
pubmed: 15846187
Vaccine. 2014 Jul 16;32(33):4131-9
pubmed: 24928791
Vaccine. 2003 Mar 28;21(13-14):1486-91
pubmed: 12615445
Drug Saf. 2017 Feb;40(2):145-152
pubmed: 27988883
Epidemiol Infect. 2007 Jan;135(1):139-43
pubmed: 16740194
Int J Environ Res Public Health. 2017 Dec 11;14(12):
pubmed: 29232882
Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S54-7
pubmed: 21640231
CMAJ. 2014 Mar 4;186(4):E157-64
pubmed: 24396098
Infect Dis Obstet Gynecol. 2016;2016:3281975
pubmed: 27559272
Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S38-46
pubmed: 22920058
Am J Obstet Gynecol. 2011 Feb;204(2):146.e1-7
pubmed: 20965490
Matern Child Health J. 2013 Jan;17(1):156-64
pubmed: 22367067
J Infect Dis. 2011 Sep 15;204(6):854-63
pubmed: 21849282
BMC Health Serv Res. 2019 Sep 2;19(1):616
pubmed: 31477095
Clin Infect Dis. 2013 May;56(9):1216-22
pubmed: 23378281
Vaccines (Basel). 2018 Jan 05;6(1):
pubmed: 29303959
N Engl J Med. 2013 Jan 24;368(4):333-40
pubmed: 23323868
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Mar;59(3):396-404
pubmed: 26753868
Vaccine. 2020 Feb 24;38(9):2202-2208
pubmed: 31992481
Vaccine. 2012 Apr 16;30(18):2892-9
pubmed: 22374374
J Clin Microbiol. 1979 Aug;10(2):184-7
pubmed: 583151
Obstet Gynecol. 2015 Sep;126(3):486-490
pubmed: 26244541
N Engl J Med. 2008 Oct 9;359(15):1555-64
pubmed: 18799552
Vaccine. 2010 Dec 10;29(1):115-22
pubmed: 21055501
PLoS One. 2013 Oct 24;8(10):e79040
pubmed: 24205364
Arch Pediatr Adolesc Med. 2011 Feb;165(2):104-11
pubmed: 20921345
Vaccine. 2013 Nov 12;31(47):5557-64
pubmed: 24076176